199 related articles for article (PubMed ID: 23965618)
1. R292K substitution and drug susceptibility of influenza A(H7N9) viruses.
Sleeman K; Guo Z; Barnes J; Shaw M; Stevens J; Gubareva LV
Emerg Infect Dis; 2013; 19(9):1521-4. PubMed ID: 23965618
[TBL] [Abstract][Full Text] [Related]
2. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
Yen HL; McKimm-Breschkin JL; Choy KT; Wong DD; Cheung PP; Zhou J; Ng IH; Zhu H; Webby RJ; Guan Y; Webster RG; Peiris JS
mBio; 2013 Jul; 4(4):. PubMed ID: 23860768
[TBL] [Abstract][Full Text] [Related]
3. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
Tang J; Zhang SX; Zhang J; Li XY; Zhou JF; Zou SM; Bo H; Xin L; Yang L; Liu J; Huang WJ; Dong J; Wang DY
Virology; 2020 Oct; 549():77-84. PubMed ID: 32853849
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
[TBL] [Abstract][Full Text] [Related]
5. [Drug susceptibility of wild-type and mutant H7N9 neuraminidase to zanamivir and oseltamivir].
Wei YN; Zhang C; Chen Q; Guo Y
Bing Du Xue Bao; 2014 Jul; 30(4):396-401. PubMed ID: 25272593
[TBL] [Abstract][Full Text] [Related]
6. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
[TBL] [Abstract][Full Text] [Related]
7. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.
Hai R; Schmolke M; Leyva-Grado VH; Thangavel RR; Margine I; Jaffe EL; Krammer F; Solórzano A; García-Sastre A; Palese P; Bouvier NM
Nat Commun; 2013; 4():2854. PubMed ID: 24326875
[TBL] [Abstract][Full Text] [Related]
8. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
Farrukee R; Butler J; Reading PC; Hurt AC
Antiviral Res; 2019 Aug; 168():68-75. PubMed ID: 31132385
[TBL] [Abstract][Full Text] [Related]
9. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.
Marjuki H; Mishin VP; Chesnokov AP; Jones J; De La Cruz JA; Sleeman K; Tamura D; Nguyen HT; Wu HS; Chang FY; Liu MT; Fry AM; Cox NJ; Villanueva JM; Davis CT; Gubareva LV
J Infect Dis; 2015 Jan; 211(2):249-57. PubMed ID: 25124927
[TBL] [Abstract][Full Text] [Related]
10. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
Sci Rep; 2013 Dec; 3():3561. PubMed ID: 24356381
[TBL] [Abstract][Full Text] [Related]
11. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.
Tang J; Gao R; Liu L; Zhang S; Liu J; Li X; Fang Q; Feng Z; Xu C; Huang W; Wang D
Sci Rep; 2021 Aug; 11(1):16293. PubMed ID: 34381119
[TBL] [Abstract][Full Text] [Related]
12. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.
Zhu W; Zhou J; Li Z; Yang L; Li X; Huang W; Zou S; Chen W; Wei H; Tang J; Liu L; Dong J; Wang D; Shu Y
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537546
[TBL] [Abstract][Full Text] [Related]
13. PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.
Wang W; Song Z; Guan W; Liu Y; Zhang X; Xu L; Li J; Yuan Z; Hu Y
Emerg Infect Dis; 2014 May; 20(5):847-9. PubMed ID: 24751348
[TBL] [Abstract][Full Text] [Related]
14. A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus.
Qi Y; Fan H; Qi X; Zhu Z; Guo X; Chen Y; Ge Y; Zhao K; Wu T; Li Y; Shan Y; Zhou M; Shi Z; Wang H; Cui L
Virus Res; 2014 Jan; 179():119-24. PubMed ID: 24211668
[TBL] [Abstract][Full Text] [Related]
15. Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
Gubareva LV; Sleeman K; Guo Z; Yang H; Hodges E; Davis CT; Baranovich T; Stevens J
J Infect Dis; 2017 Sep; 216(suppl_4):S566-S574. PubMed ID: 28934455
[TBL] [Abstract][Full Text] [Related]
16. Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
Suzuki S; Shichinohe S; Itoh Y; Nakayama M; Ishigaki H; Mori Y; Ogata-Nakahara A; Nguyen CT; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antiviral Res; 2020 Jun; 178():104790. PubMed ID: 32272175
[TBL] [Abstract][Full Text] [Related]
17. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
Liu Q; Ma J; Strayer DR; Mitchell WM; Carter WA; Ma W; Richt JA
Expert Rev Anti Infect Ther; 2014 Feb; 12(2):165-9. PubMed ID: 24350808
[TBL] [Abstract][Full Text] [Related]
18. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
Takashita E; Morita H; Nagata S; Shirakura M; Fujisaki S; Miura H; Takayama I; Arita T; Suzuki Y; Yamaoka M; Tanikawa T; Tsunekuni R; Mine J; Sakuma S; Uchida Y; Shibata A; Iwanaka M; Kishida N; Nakamura K; Kageyama T; Watanabe S; Hasegawa H;
Jpn J Infect Dis; 2022 Jul; 75(4):398-402. PubMed ID: 34980710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
